Dr Rowan French insists lasting weight loss can only be achieved through a balanced approach to psychology, exercise and ...

Debilitating headaches are reducing their quality of life, but doctors say taking these steps can help.

Wegovy® is indicated for chronic weight management in adults and adolescents (12+) with obesity or overweight and at least ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Investing.com -- 在宣布向欧洲药品管理局提交高剂量肥胖治疗药物Wegovy的批准申请后，诺和诺德公司 (NYSE: NVO )股价上涨1%。

Denmark's Novo Nordisk said on Tuesday it had submitted a new, higher dose of its obesity treatment Wegovy to the European ...

The high dose of Wegovy is one part of Novo Nordisk's plan to defend its obesity business, along with a major ...

纽约 - WW International, Inc.（即WeightWatchers）周二宣布与诺和诺德公司扩大合作，将在2025年7月以299美元的优惠价格为WeightWatchers诊所会员提供FDA批准的Wegovy（司美格鲁肽）注射剂，相当于节省200美元。根据 InvestingPro ...

The first study to put two GLP-1 weight loss drugs head-to-head found Zepbound helped people lose more weight than Wegovy.

San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...

U.S. telehealth platform looks to take advantage of Ozempic patent expiring in January, while four manufacturers filed for ...

The move follows a dramatic breakup in June between Hims & Hers and Danish drug maker Novo Nordisk, which makes the brand name weight loss drug Wegovy. Novo Nordisk accused the Hims & Hers of ...